| Aflibercept - Wikipedia, the free encyclopedia Aflibercept is a fusion protein approved in the United States for the treatment of wet macular degeneration. It is under development for the treatment of cancer. It ... Read More |
| Regeneron Announces FDA Approval of EYLEA(TM) (aflibercept ... Regeneron Announces FDA Approval of EYLEA ™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration EYLEA is the only FDA-approved ... Read More |
| Aflibercept Clinical Trial Failure: Lessons to Be Learned ... Jonathan Pan of Scientia Advisors analyzes why the failure of Aflibercept clinical trial should not have come as too much of a surprise given signs in other ... Read More |
| Sanofi-aventis and Regeneron Report Top-line Results from Phase ... Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer. Read More |
| Aflibercept (VEGF Trap) | Tumor Angiogenesis Inhibitor Learn more about Aflibercept (VEGF Trap) an investigational inhibitor of tumor angiogenesis and the ongoing clinical trials in a variety of tumor types. Read More |
| Home : EYLEA® (aflibercept) Injection EYLEA ® (aflibercept) Injection is indicated for the treatment of patients with neovascular (Wet) Age-related Macular Degeneration (AMD). EYLEA is contraindicated in ... Read More |
| News Article : Aflibercept Approved for Macular Degeneration Aflibercept Approved for Macular Degeneration. Kate Traynor. BETHESDA, MD 21 November 2011—FDA and Regeneron Pharmaceuticals on Friday announced the approval of ... Read More |
| Sanofi-Aventis And Regeneron Update Aflibercept (VEGF Trap ... Sanofi-Aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) provided an update on the clinical development program for aflibercept ... Read More |
| Eylea (Aflibercept) Drug Information: Description, User Reviews ... Learn about the prescription medication Eylea (Aflibercept), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Aflibercept in Treating Patients With Advanced Refractory ... Aflibercept in Treating Patients With Advanced Refractory, Relapsed, or Untreated Acute Myeloid Leukemia Read More |
